Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study

AIM: To assess the efficacy and safety of alternative fotemustine administration schedule in elderly patients with recurrent glioblastoma. PATIENTS & METHODS: Patients aged >65 years with recurrent glioblastoma received fotemustine (80 mg/m(2); days 1, 15, 30, 45 and 60, and subsequently ever...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CNS Oncol
Main Authors: Addeo, Raffaele, Lamberti, Giuseppe, Simonetti, Giorgia, Iodice, Patrizia, Marinelli, Alfredo, Montella, Liliana, Cappabianca, Salvatore, Gaviani, Paola, Caraglia, Michele, Prete, Salvatore Del, Silvani, Antonio
Formato: Artigo
Idioma:Inglês
Publicado: Future Medicine Ltd 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713024/
https://ncbi.nlm.nih.gov/pubmed/31290692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2019-0004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares